[HGH release after I.M. glucagon injection]

Area of Science:

• Pediatric Endocrinology
• Hormone Secretion Dynamics
• Diagnostic Testing

Background:

• Human growth hormone (HGH) is crucial for childhood growth and development.
• Assessing HGH release is vital for diagnosing growth disorders.
• Glucagon is known to stimulate various endocrine secretions.

Purpose of the Study:

• To evaluate the efficacy of intramuscular glucagon as a stimulus for HGH release.
• To compare HGH response to glucagon in normal children versus those with hypopituitarism.

Main Methods:

• Intramuscular injection of glucagon administered to 31 normal children and 4 with hypopituitarism.
• Serial blood sampling to measure HGH levels at baseline, 60, 120, and 180 minutes post-injection.
• Statistical analysis to determine the significance of HGH level changes.

Main Results:

• Normal children exhibited a significant peak HGH response at 120 minutes (12.93 ± 5.18 ng/mL, p < 0.0005).
• HGH levels at 60 and 180 minutes were also significantly elevated compared to basal levels.
• Hypopituitary dwarfs demonstrated a complete lack of HGH response following glucagon administration.

Conclusions:

• Intramuscular glucagon is a potent and reliable stimulus for HGH release in healthy children.
• The absence of HGH response to glucagon in hypopituitary dwarfs confirms the diagnostic utility of this test.
• Glucagon stimulation test can differentiate normal HGH secretion from impaired secretion in pediatric patients.